Bionow | News

CRISPR: A twist in the tale in the ongoing patent battle in Europe

Oct 22nd 2024

CRISPR mediated gene editing technology is an efficient and highly selective technique that allows the DNA of organisms to be easily and precisely modified. It is undoubtedly one of the bigg...

University secures £2.66m to develop personalised cancer treatment

Sep 15th 2023

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the ...

Leveraging protein DNA/RNA interactions in drug discovery

Oct 26th 2022

Relevant protein DNA/RNA processing complexes and their associated mechanisms provide interesting therapeutic targets to researchers, however, due to the complex and often delicate nature of...

Cresset October 2022 Newsletter

Oct 26th 2022

Read about our latest case studies, published papers, and upcoming events

Circulating tumour cells: at the forefront of cancer diagnosis and treatment

Nov 9th 2021

Could research which focusses on capturing and characterising “circulating tumour cells” (CTCs) revolutionise the diagnosis and treatment of cancer?

CG01-GMP plasmids released - Ready to start GMP production of CG01

Jun 24th 2021

The plasmids have been released at Cobra and are ready to be used as starting material for the GMP batch that will be used in the first clinical study scheduled to begin in 2022.

Bioconjugation

May 4th 2021

TCI presents Bioconjugation reagents to be used for example in drug discovery, ligand binding assays, disease diagnosis and high-throughput screening.

Cognate BioServices, and its gene therapy division Cobra Biologics, Announce Maj...

Jan 19th 2021

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project

Vaccine platform technologies to combat emerging infectious diseases

Apr 6th 2020

Encouraging progress is being made towards vaccine development against Covid-19. It is essential that we continue to incentivise and fund research into and development of these technologies.

Advancements of genetic testing

Feb 23rd 2020

With direct-to-consumer genetic tests becoming more popular and governments looking to collect and utilise genetic data in clinical and research settings, it appears the amount of genetic da...

Arcis Biotechnology and Opentrons sign distribution agreement

Jul 18th 2019

Arcis Biotechnology, the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer of affordable pip...

Cobra Biologics expands DNA vaccines, gene and immunotherapy production in Swede...

Apr 11th 2019

ATMP (Advanced therapy medicinal product) specialist Cobra Biologics builds Sweden’s first 500 litre bioreactor investing €20 million at its Matfors facility in Sundsvall.

News